Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Rugarli

Showing results (81-90 of 94) with videos related to

Pageof 10
Sort By:
International Journal of Cancer|May 4, 1999
Blockade of the Fas-triggered intracellular signaling pathway in human melanomas is circumvented by cytotoxic lymphocytesM Ferrarini, M A Imro, C Sciorati, et al.
European Journal of Immunology|June 30, 1998
Mycobacterium tuberculosis exploits the CD95/CD95 ligand system of gammadelta T cells to cause apoptosisA A Manfredi, S Heltai, P Rovere, et al.
Acta Diabetologica Latina|July 1, 1989
Impairment of lymphocyte suppressive system in recent onset insulin-dependent diabetes mellitus. Correlation with blood glucose and serum insulin levelsA Secchi, F Crosti, L Bonisolli, et al.
Diabetes|September 1, 1986
Impairment of lymphocyte-suppressive system in recent-onset insulin-dependent diabetes mellitus. Correlation with metabolic controlF Crosti, A Secchi, E Ferrero, et al.
European Journal of Cancer & Clinical Oncology|August 1, 1985
Relation between enzymatic activities and the degree of malignancy of human lymphomasP Vezzoni, R Giardini, M Raineri, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 29, 1999
Immunogenicity of apoptotic cells in vivo: role of antigen load, antigen-presenting cells, and cytokinesA Ronchetti, P Rovere, G Iezzi, et al.
International Journal of Cancer|March 27, 2001
Cytokine secretion associated with the clearance of apoptotic bodies in renal cell carcinoma patientsA Bondanza, P Rovere, A Borri, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 15, 1997
Rejection of a nonimmunogenic melanoma by vaccination with natural melanoma peptides on engineered antigen-presenting cellsM Bellone, G Iezzi, A Martin-Fontecha, et al.
Cancer Research|March 15, 1996
Particulate naturally processed peptides prime a cytotoxic response against human melanoma in vitroM P Protti, M A Imro, A A Manfredi, et al.
Cancer Treatment Reviews|June 1, 1989
Metastatic renal cell cancer treated with low-dose interleukin-2. A phase-II multicentre studyG Stoter, S D Fosså, C Rugarli, et al.
Pageof 10

Showing results (81-90 of 94) with videos related to

Sort By:
Pageof 10
International Journal of Cancer|May 4, 1999
Blockade of the Fas-triggered intracellular signaling pathway in human melanomas is circumvented by cytotoxic lymphocytesM Ferrarini, M A Imro, C Sciorati, et al.
European Journal of Immunology|June 30, 1998
Mycobacterium tuberculosis exploits the CD95/CD95 ligand system of gammadelta T cells to cause apoptosisA A Manfredi, S Heltai, P Rovere, et al.
Acta Diabetologica Latina|July 1, 1989
Impairment of lymphocyte suppressive system in recent onset insulin-dependent diabetes mellitus. Correlation with blood glucose and serum insulin levelsA Secchi, F Crosti, L Bonisolli, et al.
Diabetes|September 1, 1986
Impairment of lymphocyte-suppressive system in recent-onset insulin-dependent diabetes mellitus. Correlation with metabolic controlF Crosti, A Secchi, E Ferrero, et al.
European Journal of Cancer & Clinical Oncology|August 1, 1985
Relation between enzymatic activities and the degree of malignancy of human lymphomasP Vezzoni, R Giardini, M Raineri, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 29, 1999
Immunogenicity of apoptotic cells in vivo: role of antigen load, antigen-presenting cells, and cytokinesA Ronchetti, P Rovere, G Iezzi, et al.
International Journal of Cancer|March 27, 2001
Cytokine secretion associated with the clearance of apoptotic bodies in renal cell carcinoma patientsA Bondanza, P Rovere, A Borri, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 15, 1997
Rejection of a nonimmunogenic melanoma by vaccination with natural melanoma peptides on engineered antigen-presenting cellsM Bellone, G Iezzi, A Martin-Fontecha, et al.
Cancer Research|March 15, 1996
Particulate naturally processed peptides prime a cytotoxic response against human melanoma in vitroM P Protti, M A Imro, A A Manfredi, et al.
Cancer Treatment Reviews|June 1, 1989
Metastatic renal cell cancer treated with low-dose interleukin-2. A phase-II multicentre studyG Stoter, S D Fosså, C Rugarli, et al.
Pageof 10